1. Home
  2. BFLY vs KARD Comparison

BFLY vs KARD Comparison

Compare BFLY & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Butterfly Network Inc.

BFLY

Butterfly Network Inc.

HOLD

Current Price

$6.64

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

HOLD

Current Price

$12.74

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFLY
KARD
Founded
2011
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Electronics
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.2B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
BFLY
KARD
Price
$6.64
$12.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$11.17
★ $38.67
AVG Volume (30 Days)
★ 4.6M
600.4K
Earning Date
10-29-2026
11-22-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.82
N/A
EPS
★ N/A
N/A
Revenue
★ $97,610,000.00
N/A
Revenue This Year
$24.76
N/A
Revenue Next Year
$23.86
$50.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 18.96
N/A
52 Week Low
$1.90
$12.23
52 Week High
$10.21
$27.00

Technical Indicators

Market Signals
Indicator
BFLY
KARD
Relative Strength Index (RSI) 35.36 35.50
Support Level $6.35 $12.23
Resistance Level $9.86 $15.93
Average True Range (ATR) 0.54 1.32
MACD -0.19 0.08
Stochastic Oscillator 1.52 13.24

Price Performance

Historical Comparison
BFLY
KARD

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: